BIOMAT Database Logo BIOMAT Database Logo

Urine C-peptide, beta-cell function, and insulin requirement. 1980

E B Rappaport, and R A Ulstrom, and D D Etzwiler, and D Fife, and B E Hedlund, and M W Steffes

Urinary C-peptide excretion was investigated as a method for monitoring beta-cell function in diabetic patients and for studying the contribution of endogenous insulin production to diabetic control. Control subjects had variations in serum and urine C-peptide immunoreactivity that correlated with basal and meal-related insulin secretion. In a group of well-controlled juvenile diabetic patients, those receiving high doses of insulin had low or negligible C-peptide excretion, whereas most patients with low exogenous insulin requirements had near-normal urinary C-peptide excretion. Patients treated for diabetic ketoacidosis had recovery of beta-cell function as measured by C-peptide immunoreactivity in serial urine specimens. Thus, measurement of urinary C-peptide excretion is a simple technique that may be useful in assessing endogenous insulin production in juvenile diabetic patients.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D008297 Male Males
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E B Rappaport, and R A Ulstrom, and D D Etzwiler, and D Fife, and B E Hedlund, and M W Steffes
[C-peptide immunoreactivity CPR), urine CPR, beta-cell function (author's transl)].
June 1981, Nihon Ika Daigaku zasshi,
E B Rappaport, and R A Ulstrom, and D D Etzwiler, and D Fife, and B E Hedlund, and M W Steffes
Urinary C-peptide as a measure of beta-cell function after a mixed meal in healthy subjects: comparison of four-hour urine C-peptide with serum insulin and plasma C-peptide.
January 1983, Diabetes care,
E B Rappaport, and R A Ulstrom, and D D Etzwiler, and D Fife, and B E Hedlund, and M W Steffes
Detection of C-Peptide in Urine as a Measure of Ongoing Beta Cell Function.
January 2016, Methods in molecular biology (Clifton, N.J.),
E B Rappaport, and R A Ulstrom, and D D Etzwiler, and D Fife, and B E Hedlund, and M W Steffes
Quantitation of human pancreatic beta-cell function by immunoassay of C-peptide in urine.
January 1977, Diabetes,
E B Rappaport, and R A Ulstrom, and D D Etzwiler, and D Fife, and B E Hedlund, and M W Steffes
[Beta cell function in insulin-treated diabetes mellitus determined by C-peptide measurement].
January 1980, Ugeskrift for laeger,
E B Rappaport, and R A Ulstrom, and D D Etzwiler, and D Fife, and B E Hedlund, and M W Steffes
Insulin and C-peptide levels, pancreatic beta cell function, and insulin resistance across glucose tolerance status in Thais.
January 2007, Journal of clinical laboratory analysis,
E B Rappaport, and R A Ulstrom, and D D Etzwiler, and D Fife, and B E Hedlund, and M W Steffes
Insulinogenic indices from insulin and C-peptide: comparison of beta-cell function from OGTT and IVGTT.
June 2006, Diabetes research and clinical practice,
E B Rappaport, and R A Ulstrom, and D D Etzwiler, and D Fife, and B E Hedlund, and M W Steffes
Insulin sensitivity and beta-cell function assessed by C-peptide in young adults with cystic fibrosis.
February 1987, European journal of clinical investigation,
E B Rappaport, and R A Ulstrom, and D D Etzwiler, and D Fife, and B E Hedlund, and M W Steffes
Pancreatic B-cell function in non-insulin-dependent diabetes mellitus during successive periods of sulfonylurea and insulin treatment: serum C-peptide response to glucagon and urine C-peptide excretion.
August 1987, Endocrinologia japonica,
E B Rappaport, and R A Ulstrom, and D D Etzwiler, and D Fife, and B E Hedlund, and M W Steffes
Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus.
September 1990, Diabetologia,
Copied contents to your clipboard!